Cargando…

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by a poor prognosis and high mortality rate. Genetic mutations and altered molecular pathways serve as targets in precise therapy. Using next-generation sequencing (NGS), these aberrant alterations can be identified and used to de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Yunzhen, Gong, Yitao, Fan, Zhiyao, Luo, Guopei, Huang, Qiuyi, Deng, Shengming, Cheng, He, Jin, Kaizhou, Ni, Quanxing, Yu, Xianjun, Liu, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532113/ https://www.ncbi.nlm.nih.gov/pubmed/33008426 http://dx.doi.org/10.1186/s13045-020-00958-3

Ejemplares similares

Lewis antigen-negative pancreatic cancer: An aggressive subgroup
por: Liu, Chen, et al.
Publicado: (2020)

Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy
por: Liu, Chen, et al.
Publicado: (2020)

High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma
por: Gong, Yitao, et al.
Publicado: (2021)

Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients
por: Gong, Yitao, et al.
Publicado: (2020)

Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms
por: Deng, Shengming, et al.
Publicado: (2021)

Prognosis of distal pancreatic cancers controlled by stage
por: Luo, Guopei, et al.
Publicado: (2020)

The CRP/Albumin Ratio Predicts Survival And Monitors Chemotherapeutic Effectiveness In Patients With Advanced Pancreatic Cancer
por: Fan, Zhiyao, et al.
Publicado: (2019)

Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions
por: Zhang, Yiyin, et al.
Publicado: (2018)

Clinical implication of serum CA125 for the prediction of malignancy in mucinous cystic neoplasms of the pancreas
por: Deng, Shengming, et al.
Publicado: (2020)

AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN
por: Fan, Zhiyao, et al.
Publicado: (2019)

The role of necroptosis in cancer biology and therapy
por: Gong, Yitao, et al.
Publicado: (2019)

Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients
por: Cheng, He, et al.
Publicado: (2020)

Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma
por: Qian, Yunzhen, et al.
Publicado: (2022)

Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma
por: Qian, Yunzhen, et al.
Publicado: (2022)

Hexokinase 2 dimerization and interaction with voltage‐dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer
por: Fan, Kun, et al.
Publicado: (2019)

Glutamine deprivation induces ferroptosis in pancreatic cancer cells: Glutamine deprivation induces pancreatic cancer ferroptosis
por: Xiao, Zhiwen, et al.
Publicado: (2023)

Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer
por: Jin, Kaizhou, et al.
Publicado: (2015)

Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer
por: Liu, Chen, et al.
Publicado: (2023)

Molecular Mechanism Underlying Lymphatic Metastasis in Pancreatic Cancer
por: Xiao, Zhiwen, et al.
Publicado: (2014)

Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreas
por: Qian, Yunzhen, et al.
Publicado: (2022)

The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer
por: Guo, Meng, et al.
Publicado: (2016)

The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma
por: Li, Shuo, et al.
Publicado: (2019)

Proteome alterations in pancreatic ductal adenocarcinoma
por: Pan, Sheng, et al.
Publicado: (2020)

Prognostic value of γ‐glutamyltransferase‐to‐albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery
por: Li, Shuo, et al.
Publicado: (2019)

Molecular Characteristics of Pancreatic Ductal Adenocarcinoma
por: Ottenhof, Niki A., et al.
Publicado: (2011)

Somatic Genetic Variation in Solid Pseudopapillary Tumor of the Pancreas by Whole Exome Sequencing
por: Guo, Meng, et al.
Publicado: (2017)

Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
por: Sikdar, Nilabja, et al.
Publicado: (2018)

Application of “Papillary-Like Main Pancreatic Duct Invaginated” Pancreaticojejunostomy for Normal Soft Pancreas Cases
por: Zhang, Bo, et al.
Publicado: (2013)

Long noncoding RNA SNHG1 promotes cell proliferation through PI3K/AKT signaling pathway in pancreatic ductal adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2018)

Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression
por: Pan, Zongfu, et al.
Publicado: (2018)

Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
por: Alors-Pérez, Emilia, et al.
Publicado: (2023)

Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer
por: Zhang, Huiru, et al.
Publicado: (2022)

Advances in Pancreatic Ductal Adenocarcinoma Treatment
por: Anderson, Eric M., et al.
Publicado: (2021)

TGF-β1-induced RAP2 regulates invasion in pancreatic cancer: RAP2 regulates invasion in pancreatic cancer
por: Jin, Kaizhou, et al.
Publicado: (2022)

Distribution of Lewis and Secretor polymorphisms and corresponding CA19‐9 antigen expression in a Chinese population
por: Guo, Meng, et al.
Publicado: (2017)

Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma
por: Xu, Rui, et al.
Publicado: (2019)

Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma
por: Gartrell, Robyn D., et al.
Publicado: (2022)

Non-coding RNAs in Pancreatic Ductal Adenocarcinoma
por: Gong, Ruining, et al.
Publicado: (2020)

Possible Molecular Markers for the Diagnosis of Pancreatic Ductal Adenocarcinoma
por: Shen, Quan, et al.
Publicado: (2018)

Image-Based Molecular Phenotyping of Pancreatic Ductal Adenocarcinoma
por: Kaissis, Georgios A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fepkilmku3da2chs8vdnh10qlk